{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:33:58Z","timestamp":1787906038509,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-024-05998-7","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T07:02:17Z","timestamp":1729580537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Explainable 18F-FDG PET\/CT radiomics model for predicting EGFR mutation status in lung adenocarcinoma: a two-center study"],"prefix":"10.1007","volume":"150","author":[{"given":"Yan","family":"Zuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiufang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjie","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2544-7522","authenticated-orcid":false,"given":"Shaoli","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,22]]},"reference":[{"key":"5998_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.inffus.2019.12.012","volume":"58","author":"A Barredo Arrieta","year":"2020","unstructured":"Barredo Arrieta A, D\u00edaz-Rodr\u00edguez N, Del Ser J et al (2020) Explainable Artificial Intelligence (XAI): concepts, taxonomies, opportunities and challenges toward responsible AI. Inf Fusion 58:82\u2013115. https:\/\/doi.org\/10.1016\/j.inffus.2019.12.012","journal-title":"Inf Fusion"},{"issue":"11","key":"5998_CR3","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1007\/s00259-014-2833-4","volume":"41","author":"C Caicedo","year":"2014","unstructured":"Caicedo C, Garcia-Velloso MJ, Lozano MD et al (2014) Role of [(18)F] FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer. Eur J Nucl Med Mol Imaging 41(11):2058\u20132065. https:\/\/doi.org\/10.1007\/s00259-014-2833-4","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5998_CR6","doi-asserted-by":"publisher","unstructured":"Chadaga K, Prabhu S, Bhat V et al (2023) A decision support system for diagnosis of COVID-19 from non-COVID-19 influenza-like illness using explainable artificial intelligence. Bioeng (Basel) 10(4). https:\/\/doi.org\/10.3390\/bioengineering10040439","DOI":"10.3390\/bioengineering10040439"},{"issue":"4","key":"5998_CR2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2217\/fon.11.25","volume":"7","author":"L Cheng","year":"2011","unstructured":"Cheng L, Zhang S, Alexander R et al (2011) The landscape of EGFR pathways and personalized management of non-small-cell lung cancer. Future Oncol 7(4):519\u2013541. https:\/\/doi.org\/10.2217\/fon.11.25","journal-title":"Future Oncol"},{"key":"5998_CR4","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12885-016-2251-z","volume":"16","author":"A Cho","year":"2016","unstructured":"Cho A, Hur J, Moon YW et al (2016) Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer. BMC Cancer 16:224. https:\/\/doi.org\/10.1186\/s12885-016-2251-z","journal-title":"BMC Cancer"},{"issue":"7","key":"5998_CR5","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/j.acra.2022.10.011","volume":"30","author":"Y Cui","year":"2023","unstructured":"Cui Y, Jiang Y, Deng X et al (2023) (18)F-FDG PET-based combined baseline and end-of-treatment radiomics model improves the prognosis prediction in diffuse large B cell lymphoma after first-line therapy. Acad Radiol 30(7):1408\u20131418. https:\/\/doi.org\/10.1016\/j.acra.2022.10.011","journal-title":"Acad Radiol"},{"issue":"1","key":"5998_CR7","doi-asserted-by":"publisher","first-page":"e13963","DOI":"10.1097\/MD.0000000000013963","volume":"98","author":"SR Digumarthy","year":"2019","unstructured":"Digumarthy SR, Padole AM, Gullo RL et al (2019) Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status? Med (Baltim) 98(1):e13963. https:\/\/doi.org\/10.1097\/MD.0000000000013963","journal-title":"Med (Baltim)"},{"issue":"3","key":"5998_CR8","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1007\/s11307-019-01411-9","volume":"22","author":"D Du","year":"2020","unstructured":"Du D, Feng H, Lv W et al (2020) Machine learning methods for optimal radiomics-based differentiation between recurrence and inflammation: application to nasopharyngeal carcinoma post-therapy PET\/CT images. Mol Imaging Biol 22(3):730\u2013738. https:\/\/doi.org\/10.1007\/s11307-019-01411-9","journal-title":"Mol Imaging Biol"},{"key":"5998_CR9","doi-asserted-by":"publisher","unstructured":"Gomez OV, Herraiz JL, Udias JM et al (2022) Analysis of cross-combinations of feature selection and machine-learning classification methods based on [18]F-FDG PET\/CT radiomic features for metabolic response prediction of metastatic breast cancer lesions. Cancers (Basel) 14(12). https:\/\/doi.org\/10.3390\/cancers14122922","DOI":"10.3390\/cancers14122922"},{"issue":"3","key":"5998_CR11","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.acra.2023.09.023","volume":"31","author":"CX Hsu","year":"2024","unstructured":"Hsu CX, Yen SH (2024) Exploring tumor dissemination characteristics and prognostic factors in non-small cell lung cancer: insights from EGFR mutations and PET\/CT radiomics. Acad Radiol 31(3):1223\u20131224. https:\/\/doi.org\/10.1016\/j.acra.2023.09.023","journal-title":"Acad Radiol"},{"key":"5998_CR12","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1016\/j.csbj.2022.06.003","volume":"20","author":"C Hu","year":"2022","unstructured":"Hu C, Tan Q, Zhang Q et al (2022) Application of interpretable machine learning for early prediction of prognosis in acute kidney injury. Comput Struct Biotechnol J 20:2861\u20132870. https:\/\/doi.org\/10.1016\/j.csbj.2022.06.003","journal-title":"Comput Struct Biotechnol J"},{"key":"5998_CR10","doi-asserted-by":"crossref","unstructured":"Hur JY, Kim HJ, Lee JS et al (2018) Extracellular vesicle-derived DNA for performing EGFR genotyping of NSCLC patients. Mol Cancer 17(1)","DOI":"10.1186\/s12943-018-0772-6"},{"issue":"8","key":"5998_CR13","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1007\/s00259-022-05717-9","volume":"49","author":"C Jiang","year":"2022","unstructured":"Jiang C, Li A, Teng Y et al (2022) Optimal PET-based radiomic signature construction based on the cross-combination method for predicting the survival of patients with diffuse large B-cell lymphoma. Eur J Nucl Med Mol Imaging 49(8):2902\u20132916. https:\/\/doi.org\/10.1007\/s00259-022-05717-9","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"5998_CR15","doi-asserted-by":"publisher","first-page":"e22456","DOI":"10.1016\/j.heliyon.2023.e22456","volume":"9","author":"VV Khanna","year":"2023","unstructured":"Khanna VV, Chadaga K, Sampathila N et al (2023) A decision support system for osteoporosis risk prediction using machine learning and explainable artificial intelligence. Heliyon 9(12):e22456. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22456","journal-title":"Heliyon"},{"key":"5998_CR14","doi-asserted-by":"crossref","unstructured":"Kohei A, Yeni H, Hiroshi O (2012) Comparison of 2D and 3D local binary pattern in lung cancer diagnosis. Int J Adv Comput Sci Appl 3(4)","DOI":"10.14569\/IJACSA.2012.030416"},{"issue":"17","key":"5998_CR17","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1200\/JCO.2014.58.1736","volume":"33","author":"CK Lee","year":"2015","unstructured":"Lee CK, Wu YL, Ding PN et al (2015a) Impact of specific epidermal growth factor receptor (EGFR) mutations and clinical characteristics on outcomes after treatment with EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR-mutant lung cancer: a meta-analysis. J Clin Oncol 33(17):1958\u20131965. https:\/\/doi.org\/10.1200\/JCO.2014.58.1736","journal-title":"J Clin Oncol"},{"issue":"12","key":"5998_CR24","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1097\/RLU.0000000000000975","volume":"40","author":"SM Lee","year":"2015","unstructured":"Lee SM, Bae SK, Jung SJ et al (2015b) FDG uptake in non-small cell lung cancer is not an independent predictor of EGFR or KRAS mutation status: a retrospective analysis of 206 patients. Clin Nucl Med 40(12):950\u2013958. https:\/\/doi.org\/10.1097\/RLU.0000000000000975","journal-title":"Clin Nucl Med"},{"issue":"5","key":"5998_CR22","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1007\/s10278-021-00506-6","volume":"34","author":"M Lei","year":"2021","unstructured":"Lei M, Varghese B, Hwang D et al (2021) Benchmarking various radiomic toolkit features while applying the image biomarker standardization initiative toward clinical translation of radiomic analysis. J Digit Imaging 34(5):1156\u20131170. https:\/\/doi.org\/10.1007\/s10278-021-00506-6","journal-title":"J Digit Imaging"},{"issue":"9","key":"5998_CR20","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3348\/kjr.2022.0295","volume":"23","author":"S Li","year":"2022","unstructured":"Li S, Li Y, Zhao M et al (2022) Combination of (18)F-fluorodeoxyglucose PET\/CT radiomics and clinical features for predicting epidermal growth factor receptor mutations in lung adenocarcinoma. Korean J Radiol 23(9):921\u2013930. https:\/\/doi.org\/10.3348\/kjr.2022.0295","journal-title":"Korean J Radiol"},{"issue":"4","key":"5998_CR18","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/JTO.0000000000000095","volume":"9","author":"SH Lim","year":"2014","unstructured":"Lim SH, Lee JY, Sun JM et al (2014) Comparison of clinical outcomes following gefitinib and erlotinib treatment in non-small-cell lung cancer patients harboring an epidermal growth factor receptor mutation in either exon 19 or 21. J Thorac Oncol 9(4):506\u2013511. https:\/\/doi.org\/10.1097\/JTO.0000000000000095","journal-title":"J Thorac Oncol"},{"issue":"5","key":"5998_CR19","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.cllc.2016.02.001","volume":"17","author":"Y Liu","year":"2016","unstructured":"Liu Y, Kim J, Balagurunathan Y et al (2016) Radiomic features are associated with EGFR mutation status in lung adenocarcinomas. Clin Lung Cancer 17(5):441\u2013448e6. https:\/\/doi.org\/10.1016\/j.cllc.2016.02.001","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"5998_CR21","doi-asserted-by":"publisher","first-page":"549","DOI":"10.21037\/tlcr.2020.04.17","volume":"9","author":"Q Liu","year":"2020","unstructured":"Liu Q, Sun D, Li N et al (2020) Predicting EGFR mutation subtypes in lung adenocarcinoma using (18)F-FDG PET\/CT radiomic features. Transl Lung Cancer Res 9(3):549\u2013562. https:\/\/doi.org\/10.21037\/tlcr.2020.04.17","journal-title":"Transl Lung Cancer Res"},{"issue":"4","key":"5998_CR16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1590\/S1806-37132015000004531","volume":"41","author":"GL Lopes","year":"2015","unstructured":"Lopes GL, Vattimo EF, Castro JG (2015) Identifying activating mutations in the EGFR gene: prognostic and therapeutic implications in non-small cell lung cancer. J Bras Pneumol 41(4):365\u2013375. https:\/\/doi.org\/10.1590\/S1806-37132015000004531","journal-title":"J Bras Pneumol"},{"issue":"5","key":"5998_CR23","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00259-017-3885-z","volume":"45","author":"Z Lv","year":"2018","unstructured":"Lv Z, Fan J, Xu J et al (2018) Value of (18)F-FDG PET\/CT for predicting EGFR mutations and positive ALK expression in patients with non-small cell lung cancer: a retrospective analysis of 849 Chinese patients. Eur J Nucl Med Mol Imaging 45(5):735\u2013750. https:\/\/doi.org\/10.1007\/s00259-017-3885-z","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"5998_CR26","doi-asserted-by":"publisher","first-page":"5228","DOI":"10.1038\/s41467-020-19116-x","volume":"11","author":"W Mu","year":"2020","unstructured":"Mu W, Jiang L, Zhang J et al (2020) Non-invasive decision support for NSCLC treatment using PET\/CT radiomics. Nat Commun 11(1):5228. https:\/\/doi.org\/10.1038\/s41467-020-19116-x","journal-title":"Nat Commun"},{"key":"5998_CR28","doi-asserted-by":"publisher","unstructured":"Raptis S, Ilioudis C, Theodorou K (2024) From pixels to prognosis: unveiling radiomics models with SHAP and LIME for enhanced interpretability. Biomed Phys Eng Express 10(3). https:\/\/doi.org\/10.1088\/2057-1976\/ad34db","DOI":"10.1088\/2057-1976\/ad34db"},{"issue":"1","key":"5998_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00330-015-3814-0","volume":"26","author":"S Rizzo","year":"2016","unstructured":"Rizzo S, Petrella F, Buscarino V et al (2016) CT radiogenomic characterization of EGFR, K-RAS, and ALK mutations in non-small cell lung cancer. Eur Radiol 26(1):32\u201342. https:\/\/doi.org\/10.1007\/s00330-015-3814-0","journal-title":"Eur Radiol"},{"issue":"4","key":"5998_CR32","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1007\/s11307-020-01487-8","volume":"22","author":"I Shiri","year":"2020","unstructured":"Shiri I, Maleki H, Hajianfar G et al (2020) Next-generation radiogenomics sequencing for prediction of EGFR and KRAS mutation status in NSCLC patients using multimodal imaging and machine learning algorithms. Mol Imaging Biol 22(4):1132\u20131148. https:\/\/doi.org\/10.1007\/s11307-020-01487-8","journal-title":"Mol Imaging Biol"},{"key":"5998_CR29","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1200\/EDBK_237821","volume":"39","author":"EK Singhi","year":"2019","unstructured":"Singhi EK, Horn L, Sequist LV et al (2019) Advanced non-small cell lung cancer: sequencing agents in the EGFR-mutated\/ALK-rearranged populations. Am Soc Clin Oncol Educ Book 39:e187\u2013e197. https:\/\/doi.org\/10.1200\/EDBK_237821","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"9","key":"5998_CR31","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S1470-2045(18)30413-3","volume":"19","author":"R Sun","year":"2018","unstructured":"Sun R, Limkin EJ, Vakalopoulou M et al (2018) A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study. Lancet Oncol 19(9):1180\u20131191. https:\/\/doi.org\/10.1016\/S1470-2045(18)30413-3","journal-title":"Lancet Oncol"},{"issue":"3","key":"5998_CR30","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jtho.2016.11.2225","volume":"12","author":"N Sutiman","year":"2017","unstructured":"Sutiman N, Tan SW, Tan EH et al (2017) EGFR mutation subtypes influence survival outcomes following first-line gefitinib therapy in advanced Asian NSCLC patients. J Thorac Oncol 12(3):529\u2013538. https:\/\/doi.org\/10.1016\/j.jtho.2016.11.2225","journal-title":"J Thorac Oncol"},{"issue":"19","key":"5998_CR34","doi-asserted-by":"publisher","first-page":"17039","DOI":"10.1007\/s00432-023-05417-3","volume":"149","author":"G Wan","year":"2023","unstructured":"Wan G, Wu X, Zhang X et al (2023) Development of a novel machine learning model based on laboratory and imaging indices to predict acute cardiac injury in cancer patients with COVID-19 infection: a retrospective observational study. J Cancer Res Clin Oncol 149(19):17039\u201317050. https:\/\/doi.org\/10.1007\/s00432-023-05417-3","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"5998_CR33","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.1016\/S2589-7500(22)00024-3","volume":"4","author":"S Wang","year":"2022","unstructured":"Wang S, Yu H, Gan Y et al (2022) Mining whole-lung information by artificial intelligence for predicting EGFR genotype and targeted therapy response in lung cancer: a multicohort study. Lancet Digit Health 4(5):e309\u2013e319. https:\/\/doi.org\/10.1016\/S2589-7500(22)00024-3","journal-title":"Lancet Digit Health"},{"issue":"3","key":"5998_CR35","doi-asserted-by":"publisher","first-page":"563","DOI":"10.21037\/tlcr-19-592","volume":"9","author":"B Yang","year":"2020","unstructured":"Yang B, Ji HS, Zhou CS et al (2020) (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography-based radiomic features for prediction of epidermal growth factor receptor mutation status and prognosis in patients with lung adenocarcinoma. Transl Lung Cancer Res 9(3):563\u2013574. https:\/\/doi.org\/10.21037\/tlcr-19-592","journal-title":"Transl Lung Cancer Res"},{"key":"5998_CR36","doi-asserted-by":"publisher","first-page":"894323","DOI":"10.3389\/fonc.2022.894323","volume":"12","author":"L Yang","year":"2022","unstructured":"Yang L, Xu P, Li M et al (2022) PET\/CT radiomic features: a potential biomarker for EGFR mutation status and survival outcome prediction in NSCLC patients treated with TKIs. Front Oncol 12:894323. https:\/\/doi.org\/10.3389\/fonc.2022.894323","journal-title":"Front Oncol"},{"issue":"6","key":"5998_CR40","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10147-019-01403-3","volume":"24","author":"H Zhang","year":"2019","unstructured":"Zhang H, Cai W, Wang Y et al (2019) CT and clinical characteristics that predict risk of EGFR mutation in non-small cell lung cancer: a systematic review and meta-analysis. Int J Clin Oncol 24(6):649\u2013659. https:\/\/doi.org\/10.1007\/s10147-019-01403-3","journal-title":"Int J Clin Oncol"},{"issue":"5","key":"5998_CR37","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00259-019-04592-1","volume":"47","author":"J Zhang","year":"2020","unstructured":"Zhang J, Zhao X, Zhao Y et al (2020) Value of pre-therapy (18)F-FDG PET\/CT radiomics in predicting EGFR mutation status in patients with non-small cell lung cancer. Eur J Nucl Med Mol Imaging 47(5):1137\u20131146. https:\/\/doi.org\/10.1007\/s00259-019-04592-1","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"5998_CR41","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1007\/s00259-021-05220-7","volume":"48","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Ma XL, Zhang T et al (2021) Use of radiomics based on (18)F-FDG PET\/CT and machine learning methods to aid clinical decision-making in the classification of solitary pulmonary lesions: an innovative approach. Eur J Nucl Med Mol Imaging 48(9):2904\u20132913. https:\/\/doi.org\/10.1007\/s00259-021-05220-7","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5998_CR38","doi-asserted-by":"publisher","first-page":"1173355","DOI":"10.3389\/fonc.2023.1173355","volume":"13","author":"Y Zuo","year":"2023","unstructured":"Zuo Y, Liu Q, Li N et al (2023) Optimal (18)F-FDG PET\/CT radiomics model development for predicting EGFR mutation status and prognosis in lung adenocarcinoma: a multicentric study. Front Oncol 13:1173355. https:\/\/doi.org\/10.3389\/fonc.2023.1173355","journal-title":"Front Oncol"},{"issue":"7","key":"5998_CR39","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1002\/mp.16947","volume":"51","author":"Y Zuo","year":"2024","unstructured":"Zuo Y, Liu L, Chang C et al (2024) Value of multi-center (18) F-FDG PET\/CT radiomics in predicting EGFR mutation status in lung adenocarcinoma. Med Phys 51(7):4872\u20134887. https:\/\/doi.org\/10.1002\/mp.16947","journal-title":"Med Phys"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05998-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-024-05998-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-024-05998-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T13:06:04Z","timestamp":1730811964000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-024-05998-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["5998"],"URL":"https:\/\/doi.org\/10.1007\/s00432-024-05998-7","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,22]]},"assertion":[{"value":"1 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Fudan university shanghai cancer center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was waived from all individual participants included in this retrospective study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed patient consent was not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"469"}}